Bariatric surgery significantly improves survival outcomes among patients with obesity and cirrhosis, showing observed survival of 9.09 years compared to 8.23 years for lifestyle interventions. The incremental cost-effectiveness ratios were $18,679 for sleeve gastrectomy and $44,704 for gastric bypass in cirrhosis cohorts, proving cost-effective when compared to a $100,000 willingness-to-pay threshold for quality-adjusted life years. Researchers advocate for the broader adoption of bariatric surgery in this patient population to enhance health outcomes and reduce costs.
Journal Article by Bansal S, Bader A, Mahmud N and Kaplan DE in JAMA Surg